• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

德国医院卫生协会（DGKH）的建议：通过具有杀病毒作用的漱口水和鼻腔喷雾剂预防新冠病毒 - 2022年4月更新版

Recommendation of the German Society of Hospital Hygiene (DGKH): Prevention of COVID-19 by virucidal gargling and virucidal nasal spray - updated version April 2022.

作者信息

Kramer Axel, Eggers Maren, Exner Martin, Hübner Nils-Olaf, Simon Arne, Steinmann Eike, Walger Peter, Zwicker Paula

机构信息

Institute of Hygiene and Environmental Medicine, University Medicine Greifswald, Greifswald, Germany.

German Society of Hospital Hygiene, Berlin, Germany.

出版信息

GMS Hyg Infect Control. 2022 Jul 7;17:Doc13. doi: 10.3205/dgkh000416. eCollection 2022.

DOI:10.3205/dgkh000416
PMID:35909651
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9285112/
Abstract

The German Society of Hospital Hygiene develops guidelines, recommendations and standard operation procedures on a voluntary basis, published on the DGKH-website (https://www.krankenhaushygiene.de/). The original German version of this recommendation was published in April 2022 and has now been made available to the international professional public in English. Evaluating the current data on the efficacy of virucidal gargle/mouthwash solutions and nasal sprays against SARS-CoV-2 and in clinical trials, conducted with preventive or therapeutic objectives, recommendations are given for the prevention of COVID-19. The following areas are considered: Protection of the community when regional clusters or high incidences of infection become knownProtection of the community at low risk of infectionPre-exposure prophylaxis for the protection of healthcare workersPost-exposure prophylaxis.

摘要

德国医院卫生协会自愿制定指南、建议和标准操作程序，并发布在德国医院卫生协会网站（https://www.krankenhaushygiene.de/）上。本建议的德文原版于2022年4月发布，现以英文提供给国际专业人士。在评估目前关于杀病毒漱口水/漱口水溶液和鼻喷雾剂对SARS-CoV-2的有效性的数据以及在以预防或治疗为目的进行的临床试验的基础上，给出了预防COVID-19的建议。考虑以下几个方面：当已知出现区域聚集性感染或高感染率时对社区的保护；低感染风险社区的保护；医护人员暴露前预防；暴露后预防。

相似文献

1
Recommendation of the German Society of Hospital Hygiene (DGKH): Prevention of COVID-19 by virucidal gargling and virucidal nasal spray - updated version April 2022.德国医院卫生协会（DGKH）的建议：通过具有杀病毒作用的漱口水和鼻腔喷雾剂预防新冠病毒 - 2022年4月更新版
GMS Hyg Infect Control. 2022 Jul 7;17:Doc13. doi: 10.3205/dgkh000416. eCollection 2022.
2
Virucidal effect of povidone iodine on COVID-19 in the nasopharynx: an open-label randomized clinical trial.聚维酮碘对鼻咽部新型冠状病毒的杀病毒作用：一项开放标签随机临床试验。
Indian J Otolaryngol Head Neck Surg. 2022 Oct;74(Suppl 2):2963-2967. doi: 10.1007/s12070-021-02616-7. Epub 2021 May 18.
3
A randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARS-CoV-2 infection in high-risk contacts (MeCOVID Trial): A structured summary of a study protocol for a randomised controlled trial.一项评估褪黑素预防高危接触者 SARS-CoV-2 感染有效性的随机多中心临床试验（MeCOVID 试验）：一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 3;21(1):466. doi: 10.1186/s13063-020-04436-6.
4
Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.在医院环境中评估羟氯喹化学预防 SARS-CoV2 感染在医护人员中的疗效和安全性的对照、双盲、随机试验：一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 3;21(1):472. doi: 10.1186/s13063-020-04400-4.
5
Salivary and Nasal Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses (BBCovid): A structured summary of a study protocol for a randomised controlled trial.抗病毒漱口水（BBCovid）后唾液和鼻腔 SARS-CoV-2 病毒检测：一项随机对照试验研究方案的结构化总结。
Trials. 2020 Nov 2;21(1):906. doi: 10.1186/s13063-020-04846-6.
6
Infection prevention requirements for the medical care of immunosuppressed patients: recommendations of the Commission for Hospital Hygiene and Infection Prevention (KRINKO) at the Robert Koch Institute.免疫抑制患者医疗护理中的感染预防要求：罗伯特·科赫研究所医院卫生与感染预防委员会（KRINKO）的建议
GMS Hyg Infect Control. 2022 Apr 13;17:Doc07. doi: 10.3205/dgkh000410. eCollection 2022.
7
Repurposing 0.5% povidone iodine solution in otorhinolaryngology practice in Covid 19 pandemic.在新冠疫情期间，在耳鼻喉科实践中重新利用 0.5%聚维酮碘溶液。
Am J Otolaryngol. 2020 Sep-Oct;41(5):102618. doi: 10.1016/j.amjoto.2020.102618. Epub 2020 Jun 18.
8
Virucidal activity of nasal sprays against severe acute respiratory syndrome coronavirus-2.鼻腔喷雾剂对严重急性呼吸综合征冠状病毒 2 型的抗病毒活性。
J Hosp Infect. 2022 Feb;120:9-13. doi: 10.1016/j.jhin.2021.10.019. Epub 2021 Nov 6.
9
In Vitro Bactericidal and Virucidal Efficacy of Povidone-Iodine Gargle/Mouthwash Against Respiratory and Oral Tract Pathogens.聚维酮碘漱口水/口腔清洗剂对呼吸道和口腔病原体的体外杀菌和杀病毒效果
Infect Dis Ther. 2018 Jun;7(2):249-259. doi: 10.1007/s40121-018-0200-7. Epub 2018 Apr 9.
10
A quadruple blind, randomised controlled trial of gargling agents in reducing intraoral viral load among hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial.一项关于漱口剂在降低住院 COVID-19 患者口腔病毒载量中的四重盲、随机对照试验：一项随机对照试验研究方案的结构化总结。
Trials. 2020 Sep 14;21(1):785. doi: 10.1186/s13063-020-04634-2.

引用本文的文献

1
Saline nasal irrigation and gargling in COVID-19: Part II. Outcomes in Omicron and risk-benefit for self-care.新冠病毒感染中鼻腔盐水冲洗和漱口：第二部分。奥密克戎毒株感染的结果及自我护理的风险效益
Front Public Health. 2025 Aug 20;13:1462286. doi: 10.3389/fpubh.2025.1462286. eCollection 2025.
2
Can toothbrushing reduce the intraoral viral load of SARS-CoV-2? A pilot study with a dentifrice containing an antimicrobial phthalocyanine derivative.刷牙能降低口腔内严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的病毒载量吗？一项使用含有抗菌酞菁衍生物牙膏的初步研究。
GMS Hyg Infect Control. 2024 Jun 5;19:Doc32. doi: 10.3205/dgkh000487. eCollection 2024.
3
Risk of SARS-CoV-2 infection in dental healthcare workers - a systematic review and meta-analysis.牙科医护人员感染严重急性呼吸综合征冠状病毒2的风险——一项系统评价和荟萃分析
GMS Hyg Infect Control. 2024 Mar 5;19:Doc09. doi: 10.3205/dgkh000464. eCollection 2024.
4
A novel inhibitor of SARS-CoV infection: Lactulose octasulfate interferes with ACE2-Spike protein binding.一种新型的严重急性呼吸综合征冠状病毒（SARS-CoV）感染抑制剂：乳糖八硫酸酯干扰血管紧张素转换酶2（ACE2）与刺突蛋白的结合。
Heliyon. 2023 Dec 3;10(1):e23222. doi: 10.1016/j.heliyon.2023.e23222. eCollection 2024 Jan 15.
5
Improving Nasal Protection for Preventing SARS-CoV-2 Infection.增强鼻腔防护以预防新型冠状病毒2感染
Biomedicines. 2022 Nov 17;10(11):2966. doi: 10.3390/biomedicines10112966.
6
Health promotion through structured oral hygiene and good tooth alignment.通过规范口腔卫生和良好的牙齿排列促进健康。
GMS Hyg Infect Control. 2022 May 10;17:Doc08. doi: 10.3205/dgkh000411. eCollection 2022.

本文引用的文献

1
A recommendation of PHTALOX® for preventing infection and progression of COVID-19: a 1-year summarized update of scientific approaches.关于PHTALOX®预防新型冠状病毒肺炎感染及病情进展的建议：科学方法的1年总结更新
GMS Hyg Infect Control. 2022 Jan 31;17:Doc03. doi: 10.3205/dgkh000406. eCollection 2022.
2
Antiviral effect of mouthwashes against SARS-COV-2: A systematic review.漱口水对严重急性呼吸综合征冠状病毒2的抗病毒作用：一项系统评价。
Saudi Dent J. 2022 Mar;34(3):167-193. doi: 10.1016/j.sdentj.2022.01.006. Epub 2022 Feb 1.
3
A model of factors influencing COVID-19 vaccine acceptance: A synthesis of the theory of reasoned action, conspiracy theory belief, awareness, perceived usefulness, and perceived ease of use.影响 COVID-19 疫苗接种接受度的因素模型：理性行为理论、阴谋论信念、意识、感知有用性和感知易用性的综合。
PLoS One. 2022 Jan 12;17(1):e0261869. doi: 10.1371/journal.pone.0261869. eCollection 2022.
4
COVID-19 in Pediatric Patients: A Systematic Review.儿童 COVID-19 患者：系统评价。
J Neurosurg Anesthesiol. 2022 Jan 1;34(1):141-147. doi: 10.1097/ANA.0000000000000803.
5
Iota-carrageenan and xylitol inhibit SARS-CoV-2 in Vero cell culture.iota-卡拉胶和木糖醇可抑制 Vero 细胞培养中的 SARS-CoV-2。
PLoS One. 2021 Nov 19;16(11):e0259943. doi: 10.1371/journal.pone.0259943. eCollection 2021.
6
Virucidal activity of nasal sprays against severe acute respiratory syndrome coronavirus-2.鼻腔喷雾剂对严重急性呼吸综合征冠状病毒 2 型的抗病毒活性。
J Hosp Infect. 2022 Feb;120:9-13. doi: 10.1016/j.jhin.2021.10.019. Epub 2021 Nov 6.
7
The effectiveness of various gargle formulations and salt water against SARS-CoV-2.各种漱口配方和盐水对 SARS-CoV-2 的有效性。
Sci Rep. 2021 Oct 15;11(1):20502. doi: 10.1038/s41598-021-99866-w.
8
Estimating salivary carriage of severe acute respiratory syndrome coronavirus 2 in nonsymptomatic people and efficacy of mouthrinse in reducing viral load: A randomized controlled trial.估算无症状人群中严重急性呼吸综合征冠状病毒 2 的唾液携带情况以及漱口液降低病毒载量的效果：一项随机对照试验。
J Am Dent Assoc. 2021 Nov;152(11):903-908. doi: 10.1016/j.adaj.2021.05.021. Epub 2021 Jun 11.
9
In vitro studies evaluating the efficacy of mouth rinses on Sars-Cov-2: A systematic review.评估漱口液对 SARS-CoV-2 疗效的体外研究：系统评价。
J Infect Public Health. 2021 Sep;14(9):1179-1185. doi: 10.1016/j.jiph.2021.07.020. Epub 2021 Aug 5.
10
Mouthwashes with CPC Reduce the Infectivity of SARS-CoV-2 Variants In Vitro.含 CPC 的漱口水可降低 SARS-CoV-2 变异株的体外传染性。
J Dent Res. 2021 Oct;100(11):1265-1272. doi: 10.1177/00220345211029269. Epub 2021 Jul 20.